Navigation Links
ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
Date:2/6/2008

RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury, today reported results for the second quarter and first six months of fiscal 2008.

Revenues for the quarter ended December 31, 2007, were $5.5 million. This compares with revenues of $3.7 million for the second quarter of fiscal 2007 and $3.6 million for the first quarter of fiscal 2008. Total disposable revenues were $2.6 million, a 44 percent increase over disposable revenues of $1.8 million in the second quarter a year ago.

The Company reported a net loss of $1.7 million, or $0.03 per share, in the second quarter of fiscal 2008, versus a loss of $2.0 million, or $0.04 per share, in the second quarter a year ago. At December 31, 2007, ThermoGenesis had $30.5 million in cash, cash equivalents and short-term investments. Total cancellable backlog at the end of the second fiscal quarter was $3.9 million, a 50 percent increase over the $2.6 million in cancellable backlog a year ago.

"As we discussed in our January 10th update news release, the primary growth drivers during the quarter were increased AXP(TM) AutoXpress Platform (AXP) bag set shipments, improved BioArchive(R) System sales and growth in CryoSeal(R) FS System and disposable sales," noted Dr. William Osgood, the Company's Chief Executive Officer.

Osgood said the Company's results reflect its success in addressing AXP bag set production quality. In addition, the Company shipped 8 BioArchive devices during the quarter which compares to 3 devices shipped in the prior year same quarter, bringing the total number of installed BioArchiv
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
10. Helix BioPharma Corp. announces fiscal 2007 results
11. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...
(Date:5/21/2013)... , May 21, 2013  Personal Genome Diagnostics ... its proprietary methodologies and expertise in genomic analysis ... targets in collaboration with Blueprint Medicines.  PGDx is ... identifying genomic alterations in tumors, and Blueprint Medicines ... inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Inflamax ... of the ITN to design the study, which ... two key clinical models used in the study ... and Nasal Allergen Challenge (NAC) models. Although both ... numerous publications, to date no direct comparison between ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 PathoGenetix, Inc., ... bacterial strain typing, announced today that it has successfully ... E. coli strains obtained from the Centers for Disease ... Scanning™ (GSS™) technology. The findings are detailed in a ... the American Society for Microbiology in Denver on Monday. ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
... SkinHealth Technology introduces a skin animation video depicting the ... Treatment Balm on skin affected with psoriasis. ... Psoriasis treatment The powerful, ... and botanical emollients -- with a proven skin protectant ...
... of Technology have for the first time provided ... growing high-quality layers of epitaxial graphene on silicon ... vapor pressure of gas-phase silicon in the high-temperature ... basic principle for growing thin layers of graphene ...
... 2011 SuperNova Diagnostics®, Inc., a privately-held global diagnostics ... that Neil J. Campbell, president and CEO, will be ... D.C. on September 27, 2011 at 11:00 a.m. in ... in Washington, D.C.   The presentation will ...
Cached Biology Technology:Skin Animation Highlights New Dermatological Formula That Targets Psoriasis 2Controlling silicon evaporation allows scientists to boost graphene quality 2Controlling silicon evaporation allows scientists to boost graphene quality 3SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C. 2
(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/17/2013)... Research Foundation announced a new grant that intends to ... one of today,s most exciting areas of science, and ... Awards Panel selected Andrew T. Chan, MD, MPH and ... School, Boston, as the 2013 AGA-Elsevier Gut Microbiome Pilot ... funding, commencing in July 2013, to test the overarching ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... Reportlinker.com announces that a new market research ... Biometrics: Technologies and Global Markets ... report studies the global as well as regional markets ... locating newer markets and expanding the present market position ...
... If you,re unsure about what foods to eat to maintain ... to point people back to basics and reach for ... edition of American Journal of Clinical Nutrition reveals ... to an 18% decreased risk of cardiovascular disease. The ...
... TEMPE, Ariz. Enormous uncertainty. These two words ... in the 21st century. Reservoirs have dipped to their ... forecasts for even warmer summers are predicted. Despite this ... need to be fearful because positive impacts can be ...
Cached Biology News:Reportlinker Adds Biometrics: Technologies and Global Markets 2Reportlinker Adds Biometrics: Technologies and Global Markets 3Reportlinker Adds Biometrics: Technologies and Global Markets 4Reportlinker Adds Biometrics: Technologies and Global Markets 5Reportlinker Adds Biometrics: Technologies and Global Markets 6Reportlinker Adds Biometrics: Technologies and Global Markets 7Reportlinker Adds Biometrics: Technologies and Global Markets 8Reportlinker Adds Biometrics: Technologies and Global Markets 9Reportlinker Adds Biometrics: Technologies and Global Markets 10Reportlinker Adds Biometrics: Technologies and Global Markets 11Reportlinker Adds Biometrics: Technologies and Global Markets 12Reportlinker Adds Biometrics: Technologies and Global Markets 13Reportlinker Adds Biometrics: Technologies and Global Markets 14Reportlinker Adds Biometrics: Technologies and Global Markets 15Reportlinker Adds Biometrics: Technologies and Global Markets 16Reportlinker Adds Biometrics: Technologies and Global Markets 17Reportlinker Adds Biometrics: Technologies and Global Markets 18Reportlinker Adds Biometrics: Technologies and Global Markets 19Reportlinker Adds Biometrics: Technologies and Global Markets 20Reportlinker Adds Biometrics: Technologies and Global Markets 21Reportlinker Adds Biometrics: Technologies and Global Markets 22Go ahead, drink your milk 2A positive step in the face of uncertainty 2
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit polyclonal to MAP3K12 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH from the C-terminal region of human MAP3K12 Entrez Gene ID: 7786 Swiss ...
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: